[1] |
Ferlin G, Borsato N, Camerani M, et al.
New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan[J]. J Nucl MedJ Nucl Med, 1983, 24(5): 438-441.
|
[2] |
Basso LV, Keeling C, Goris ML.
Parathyroid imaging[J]. Use of dual isotope scintigraphy for the localization of adenoma before surgery. Clin Nucl MedUse of dual isotope scintigraphy for the localization of adenoma before surgery. Clin Nucl Med, 1992, 17(5): 380-383.
|
[3] |
Hauty M, Swartz K, McClung M, et al.
Technetium-thallium scintiscanning for localization of parathyroid adenomas and hyperplasia[J]. A reappraisal. Am J SurgA reappraisal. Am J Surg, 1987, 153(5): 479-486.
doi: 10.1016/0002-9610(87)90798-7
|
[4] |
Coakley AJ, Kettle AG, Wells CP, et al.
99mTc-sestamibi-a new agent forparathyroid imaging[J]. NuclMedCommunNuclMedCommun, 1989, 10(11): 791-794.
|
[5] |
Melloul M, Paz A, Koren R, et al.
99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance[J]. Eur J Nucl MedEur J Nucl Med, 2001, 28(2): 209-213.
doi: 10.1007/s002590000406
|
[6] |
Tomas MB, Pugliese PV, Tronco GG, et al.
Pinhole versus parallelhole collimators for parathyroid imaging: an intraindividual comparison[J]. J Nucl Med TechnolJ Nucl Med Technol, 2008, 36(4): 189-194.
doi: 10.2967/jnmt.108.055640
|
[7] |
De Feo ML, Colagrande S, Biagini C, et al.
Parathyroid glands combination of 99mTc-MIBI scintigraphy and US for demonstration of parathyroid glands and nodules[J]. RadiologyRadiology, 2000, 214(2): 393-402.
doi: 10.1148/radiology.214.2.r00fe04393
|
[8] |
Hindié E, Mellière D, Jeanguillaume C, et al.
Parathyroid imaging using simultaneous double-window recording of technetium-99msestamibi and iodine-123[J]. J NucI MedJ NucI Med, 1998, 39(6): 1100-1105.
|
[9] |
Chen CC, Holder LE, Scovill WA, et al.
Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT[J]. J Nucl MedJ Nucl Med, 1997, 38(6): 834-839.
|
[10] |
Palestro CJ, Tomas MB, Tronco GG.
Radionuclide imaging of the parathyroid glands[J]. Semin Nucl MedSemin Nucl Med, 2005, 35(4): 266-276.
doi: 10.1053/j.semnuclmed.2005.06.001
|
[11] |
Billotey C, Sarfati E, Aurengo A, et al.
Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy[J]. J Nucl MedJ Nucl Med, 1996, 37(11): 1773-1778.
|
[12] |
Gayed IW, KimEE, BroussardWF, etal.
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia[J]. J Nucl MedJ Nucl Med, 2005, 46(2): 248-252.
|
[13] |
Neumann DR, Obuchowski NA, Difilippo FP.
Preoperative 123I/ 99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism[J]. J Nucl MedJ Nucl Med, 2008, 49(12): 2012-2017.
doi: 10.2967/jnumed.108.054858
|
[14] |
Ishibashi M, Nishida H, Kumabe T, et al.
Tc-99m tetrofosmin[J]. A new diagnostic tracer for parathyroid imaging. Clin Nucl MedA new diagnostic tracer for parathyroid imaging. Clin Nucl Med, 1995, 20(10): 902-905.
|
[15] |
Hiromatsu Y, Ishibashi M, Nishida H, et al.
Technetium-99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism[J]. Intern MedIntern Med, 2000, 39(2): 101-106.
doi: 10.2169/internalmedicine.39.101
|
[16] |
Fjeld JG, Erichsen K, Pfeffer PF, et al.
Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi[J]. J Nucl MedJ Nucl Med, 1997, 38(6): 831-834.
|
[17] |
Sundin A, Johansson C, Hellman P, et al.
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism[J]. J Nucl MedJ Nucl Med, 1996, 37(11): 1766-1770.
|
[18] |
Beggs AD, Hain SF.
Localization of parathyroid adenomas of using 11C-methionine positron emission tomography[J]. Nucl Med CommunNucl Med Commun, 2005, 26(2): 133-136.
doi: 10.1097/00006231-200502000-00009
|
[19] |
Otto D, Boerner AR, Hofmann M, et al.
Pre-operative localization of hyperfunctional parathyroid tissue with 11C-methionine PET[J]. Eur J Nucl Med Mol ImagingEur J Nucl Med Mol Imaging, 2004, 31(10): 1405-1412.
|
[20] |
Weber T, Cammerer G, Schick C, et al.
C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism[J]. Horm Metab ResHorm Metab Res, 2010, 42(3): 209-214.
doi: 10.1055/s-0029-1243185
|
[21] |
Bahar G, Feinmesser R, Joshua BZ, et al.
Hyperfunctioning intrathyroid parathyroid gland: a potential cause of failure in parathy-roidectomy[J]. SurgerySurgery, 2006, 139(6): 821-826.
doi: 10.1016/j.surg.2005.11.009
|
[22] |
Piga M, Bolasco P, Satta L, et al.
Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism[J]. J Nucl MedJ Nucl Med, 1996, 37(4): 565-569.
|
[23] |
Takeuchi H, Greep NC, Hoon DS, et al.
Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging[J]. J Clin Endocrinol MetabJ Clin Endocrinol Metab, 2007, 92(5): 1785-1790.
doi: 10.1210/jc.2006-2010
|
[24] |
Nichols KJ, Tomas MB, Tronco GG, et al.
Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings[J]. RadiologyRadiology, 2008, 248(1): 221-232.
doi: 10.1148/radiol.2481071066
|
[25] |
Mihai R, Gleeson F, Buley ID, et al.
Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients[J]. World J SurgWorld J Surg, 2006, 30(5): 697-704.
doi: 10.1007/s00268-005-0338-9
|
[26] |
Torregrosa JV, Fernández-Cruz L, Canalejo A, et al.
99mTc-sestamibi scintigraphyandcell cycle in parathyroid glands of secondary hyper-parathyroidism[J]. World J SurgWorld J Surg, 2000, 24(11): 1386-1390.
doi: 10.1007/s002680010229
|
[27] |
Kao A, Shiau YC, Tsai SC, et al.
Technetium-99m methoxyisobutilisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression[J]. Eur J Nucl Med Mol ImagingEur J Nucl Med Mol Imaging, 2002, 29(8): 1012-1015.
doi: 10.1007/s00259-002-0817-2
|
[28] |
Yamaguchi S, Yachiku S, Hashimoto H, et al.
Relation between technetium-99m methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands[J]. World J SurgWorld J Surg, 2002, 26(1): 29-34.
doi: 10.1007/s00268-001-0177-2
|
[29] |
Shiau YC, Tsai SC, Wang JJ, et al.
Detecting parathyroid adenoma using technetium-99m tetrofosimin: comparison with P-glycoprotein and multidrug resistance related protein expression—a preliminary report[J]. Nucl Med BiolNucl Med Biol, 2002, 29(3): 339-344.
doi: 10.1016/S0969-8051(01)00314-6
|
[30] |
Huang WT.
Size and P-glycoprotein expression limit 99mTc-tetrofosmin uptake in parathyroid adenomas[J]. Nucl Med CommunNucl Med Commun, 2002, 23(10): 1001-1004.
doi: 10.1097/00006231-200210000-00010
|
[31] |
Fuster D, Ybarra J, Torregrosa JV, et al.
Double-phase parathyroid 99mTc-sestamibi scintigraphy in chronic haemodialysis patients: correlation with biochemical markers of parathyroid function[J]. Nucl Med CommunNucl Med Commun, 2003, 24(1): 85-90.
doi: 10.1097/00006231-200301000-00019
|